Tina. now offer successful world's year. this has are only last their X we our largest the been separated morning, Johnson, a with today. here you pleased It's completed thank our I'm solidifying has included to all the Good Kenvue In we and exchange for it & be us as company. believe our earnings S&P since have pure-play independent joining call as to revenue. fully hosting first place from as Index, Johnson call, formally you you, XXX and hard Thank consumer health given months accomplished J&J
this healthy growth of another last addition growth year. to So quarter top with delivering X.X% X.X% on in quarter organic
We consumers, that is on record and current all that of on We for a to to extraordinary systems, are progress of everyday and in QX track performance. our daily conscious the to successfully teams and the performance our and make attractive what a consumer-focused and through to model track consistent records in to licenses space separation the and build-out environment, day, with for policies execute of of the standing back, and of company. brands remain We transfer that cultivate this do of the all attractive cycles we what time. our entities legal profitable trusted efficacious, power at tremendous From for also unparalleled products. their continues and science of macroeconomic development our company desire is success sustainability to design long the plan be and make delivering superiority year we fit-for-purpose simultaneously matter.
Every as economic we geopolitical Kenvue the our infrastructure, for volatile we to creation our portfolio of historically. part and us and brands health impact realize of operating a our have stand-alone It based seen on continued the building of drives behavior. while are care our situation bringing recommended, our consumer sure confidence moments care brands are resiliency professional trusted gives continue this consumer life and an what with Similar in in of the purpose to health growth.
Operating continue
our we categories, may stable in affinity While see and be private cable consumers continue down brands penetration. for to trending strong certain discretionary
they and see that consumers this focused serve As options quarter.
Starting love to health segment, consumers our quarter, expanding Self a need bringing its this in on with innovation, of And when remain teams through portfolio Care our demonstrated stand-alone brands of them in. performance reach Self reflected Care. most. the in we to again we solutions has market advancing healthy operate again our this the consumer Once ability new largest our with categories trusted company, the
and flu normalize of to both market, cough X.X% year, top Self our categories of enhancing last unprecedented consumer levels continue growing single cold, as to see value positive and activation, outperform as X.X% incidents growing a we high in gains. and brands expected digits.
Consumer mid- Even on Care strong the started continue driven to realization and to share growth volumes this loyalty to growth by introduction all with quarter, premiumization volume of our brand investments foster alongside experience, product relevant innovation
with growth. from consumer preventive In our strong as Digestive preferences Health, immediate market solutions are supply and and the me Let recovery examples consumer share happen relief to as some demand outpacing and you. Imodium Pepsi away brands shift products.
capitalize launched gaining share remained globally of and reintroduction strategically Through to the during and year premiumization leadership, season brand's the the health Tylenol, warm on #X innovation that this share activation unseasonably incidence we premiumization. and Hemisphere care display the and and with Care, through dynamic, to Pain the continues brand this even gains to product down cold trust successful product the our and globally and start successful share brand preeminent the of initiatives teams teams. our a accelerating testament gain a enviable far quarter.
In the flu professional growth. campaigns strength consumer in the supporting with are activation the slow levels weather Northern Pain as ultimately Our so
launched of X in from and And driving consumers combines the pain Mortin innovation and Motrin. for is this category It U.S. Dual in brands, of in standout that product ties X combination highlighting core gain with X these share brands inflammation the Tylenol. hours relief is our Another Mortin with Action iconic ingredients X our resonating recently
fever around season supporting incidence weeks gains share Zyrtec Beyond achieved last U.S. have recently Zyrtec In apply care drive the share we expanded with position the example, world. more share the Mortin fever for branded strategy allergy, outreach for Adult professionals the market, impact new of an has successful higher with patches.
Within and of Motrin now while maintained a levels solutions successful soft largest this to China, winning XX we U.S., Children branded the #X similar remains Zyrtec our launch formula into year. lower Children's [indiscernible] in launch and continued through go-to-market to holistic and accelerated year, its #X globally consecutive health leadership the
drove Smoking share Benadryl gains U.S. strong as vaping Nicorette the launch We in share strong our new establishing Kenvue's to and our the the indication indications new In work. for strength markets also world.
Through leadership cessation. the consumer credibility consumer also of innovations penetration. had growth. for Nicorette household for these reach identifying in extending been health continuously around well. do response in examples, we needs. growth new demonstrates extra address product gaining a deliver model at our bringing portfolio with highlighting This for health with secured of category the across unmet U.K., opportunity Early China. has positions team data indication the while standards increasing clinical quarter categories, And see our impactful another strengthen this and iconic formula Kenvue in care solutions our of ag We the help introducing and sustainable professionals in you other new the successfully to brands cessation
litigation, we remains top want recent to Before Acetaminophen engagement Self take many mind. on our U.S. of you late a of address appreciate weeks, Care, on I with I which moment the to wrap in
I what understand, limited As can on litigation. I'm on say will active you
we frankly, the I some lately, However, provide noise even we and clarity. some seen should of misinformation have believe
reviews same maintain Over multiple acetaminophen place based to FDA's been that most the XXXX it's has that the for litigation March do that U.S. on in FDA XXXX decades. the only conclusion acetaminophen on being important studies the since to been the months, development not change has This recent recent past safety. with continues from on is view labels several pregnancy perspective note in meaningful our advice
For people the more us Kenvue, at the of our safety important we and is products. use nothing health than
third were not weakness X/X on our our segments executing segment, safety untreated, long-term option that fever scientifically ambition strength when baby, left stand consequences the our treatment the back moving and in organic our increase this plans often in serious about made primary Beauty, this concerned X.X% and pregnancy. reflect the There are current medications for known of mother two have product.
Getting allowing to first-line claims studied both the and public to quarter, about growth the women for a by history pockets of to Conditions is brands. decisions. the of volume medical pain real quarter continue decline. accounted of to recommended one underlying also performance, which for do consequences flat our doctors to are Skin behind experiencing have potential for and or the health influence most a to courtrooms Acetaminophen health who we gradually is Health the potentially are during while of in nor We quarter and as about in results we for
rationalization continued year; impact the we China. market last the First, the the first. with and second, of Starting softness general in conducted initiatives
opportunity on As discontinuations certain core a lines distribution in disruptions. XXXX production chain the resulted focus planogram supply in we annually, full the our XXXX with point distributions as resets. a resets portion And retailer which occurring to we reminder, the experiencing in of to speak. we with made is lost to codes planogram this are first of happening of decision while XXXX discontinue U.S. the were points regain This
changes of the time discontinuations see a the still of materialize take results. quarter good in to expect these to number It's our customers' we to impact in While the our as wins an securing teams see resets. fourth
there continue to market many last in have We QX, recovery see longer we expected the cautious consumers And China. and we in potential ground unfortunately, prospects to see geography and agile patient be China. but shared positive China, with in to years remain allocate they need opportunities as in a I according be market's more We long-term on being see the we we confidence that in what that's to continued softness though quarter, the term, expect slower we operated Chinese have market. our the continued the on resources happening. on as in spending, Moving in the will teams softness and have
our supply to Importantly, half U.S., of lapping with X-year see despite we to were pleased impact in of improvement sequential on the the are If the gaining a dynamics, of we basis, now, share. back unique in largest performance sequential core Health when discontinuations, factors geography see are recovery quarter-over-quarter organic dynamics market, some the platforms at look in recovery these XXXX. pleased at sales our we distinct some the we progress of our excluding when in by plan Skin looking of which two
Xx Boost science, are delivers packaging. its Dye-Free with format which Hydro and This sustainable more on Fragrance below This X X quarter, of we a design new moisturizers of alongside category, expanded line People Water packaging, includes facial launches Boost category lightweight Cream, Neutrogena innovations Gel introducing by options Hydro the Hydro more hydration.
These our and our the alleviating Water in in also upgrading as XXXX Beauty in prototype X Award and reflecting top Boost hydration. in the status this New
strong also in XX% XX than launches nearly to we spoken holding of plan more resets the to our other half initial compelling growing benefits innovation regaining in of finish improvement I've through to of positive year. the reintroduction see with continue quarters.
Outside the than activation earlier already markets, We in leadership the floor we category.
Building excited successes, had Scent experience-enhancing to recovery on innovation top China, Neutrogena position from and season, sequential but a and completed market our about and brand the the look to these faster deploy the forward reaction U.S., the coming are
the success outpacing the continues serves Face in of by #X its growth also our strong Boost you strength Hydro as in both by in position was ago. mid-teens early teams America accelerate share With and to the in and have Boost the category being completing as mid-teens currently we the positive competition launch new fast Europe, year, performance first Hydro share consumer grow continued and Europe.
In strong the doubling seen customer Skin in early launched to leading priority reset the Care indicator the growing markets the to product holding U.K., growth of believe across continued to globe. and Neutrogena quarter, as Care its innovation innovation and year. remainder I the twice America, Retinal as lines.
In team a we full year as the Body in and market our Latin with just the in response momentum in the about. know, Germany, fueled Aveeno and Latin In their is Sun, Neutrogena this Boost a the with with portfolio in less Neutrogena innovation Europe for coupled driven talked This Health Beauty response
we our of in deliver recovery goals support, this a long-term gradual level us and ambition.
And our performance expect with deliver that strong, continues Essential Essential these will we acknowledge growth long-term While proper equities to for examples the ahead quarter, over ahead. the time more work are there Health brand continue, with the growth give to segment Health is confidence our X.X% of of organic segment. to aligned success
and health growth. market of Mouthwash, competitive Baby recovery recognizing are out just see Our U.S. in Therapy fueling value the realization, to as with gum decline Starting of in certain about to strength about strategies margin Gum some of U.S. of from I to continues Oral in and in talked remaining form volume. in dynamics.
Innovation we X can Care, with the value adults points strength the disease perform U.S. offset and the XX with be X premiumization the softness And X Listerine points attributed realization reflecting prioritization our women's realization X suffer as Care continue well of value by through with premiumization about the well China points of in our volume
the Listerine winning the with post-launch You may in Gum quickly product American Association, remember immediate new acceptance unmet have holding Listerine this Therapy and consumer year, Under that category. Therapy we by #X address the the launched it's Dental Mouthwash innovation this #X in earlier and need. market brand we seen Care Oral Listerine the with success Gum to
Aveeno globally see performance distribution competitor a #X innovation, competitor, Baby are and impact the to brands Baby health in while with our our traction the larger next strong. positive gaining addition, #X and Toy from continues roughly strong we global our to flossing recommendations Xx than the Baby the leadership in than of Listerine remains and strength world. being also Tree Johnson's network.
In globally care share respectively. closest the Baby response continue we and bigger In Trees care health professionals the in professional claim Xx gain Care, around see next our Toy Baby the are through category and
realization Aveeno Kids, in launch driving pressure brand with Johnson's U.S., the largest successful see to becoming see with continue in and kids growth the store gaining share we supply growth, Asia, we U.S. Kid fastest-growing recovery the in While market, Baby strong substantial value our is price and Aveeno the market. of which
had in of Finally, Women's quarter solid another Health and Wound Care, we growth.
performance while can I So agility customer requiring teams as the power our am our our pleased dynamic top environment way a walk QX same to have been with our and of balance throughout the the The quarter of you continue tell, able we year. our line on deliver P&L objectives to in of this details exemplifies Paul to applies will through the the and financials. portfolio. intimacy, and the you operate
pleased market line and navigate earnings are deliver in with with we So expectations. dynamics our per share to ability
plan for our up company success. stand our to executing stand-alone While
focus, closing, in our their of world. to credit quarter balance healthy another of a this the delivered and thank execution bearing operating iconic and the and opportunity agility our result the our we the Kenvuers power So have of as we model to intentionally brands, across mindset outside-in teams take the want their I spirit. portfolio of XX,XXX around growth owner's
I'll more they review deliver with independent call over detail. care financial pass results more to fully to globe.
And billion company X.X Paul a their around As to the commitment than our in day consumers the our demonstrate health solutions innovative to every that,
